# Bootstrap 95% Confidence Intervals — CMS125 (n=10,000 resamples)

All publication-scale experiments (n=499–500 patients).

## GPT-4o guideSupp (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **97.9%** | 95.24% | 100.0% |
| Recall | **95.24%** | 91.5% | 98.44% |
| F1 | **96.55%** | 94.16% | 98.5% |
| Auditability | **98.0%** | 96.6% | 99.2% |

## GPT-4o zeroShot (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **36.11%** | 30.93% | 41.32% |
| Recall | **79.59%** | 72.86% | 85.92% |
| F1 | **49.68%** | 44.06% | 54.95% |
| Auditability | **52.6%** | 48.2% | 56.8% |

## Llama 3.3 70B guideSupp (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **83.85%** | 77.91% | 89.29% |
| Recall | **91.84%** | 87.25% | 96.06% |
| F1 | **87.66%** | 83.44% | 91.3% |
| Auditability | **92.4%** | 90.0% | 94.6% |

## Qwen 3 80B guideSupp (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **64.52%** | 58.05% | 70.67% |
| Recall | **95.24%** | 91.45% | 98.5% |
| F1 | **76.92%** | 71.88% | 81.44% |
| Auditability | **82.6%** | 79.2% | 85.8% |

## Llama 3.3 70B zeroShot (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **48.55%** | 40.31% | 56.92% |
| Recall | **45.58%** | 37.65% | 53.74% |
| F1 | **47.02%** | 39.6% | 53.87% |
| Auditability | **69.8%** | 65.8% | 73.8% |

## Qwen 3 80B zeroShot (n=500)

| Metric | Observed | 95% CI Lower | 95% CI Upper |
|---|---|---|---|
| Precision | **33.25%** | 28.71% | 37.85% |
| Recall | **91.16%** | 86.34% | 95.56% |
| F1 | **48.73%** | 43.49% | 53.7% |
| Auditability | **43.6%** | 39.2% | 47.8% |

